STOCK TITAN

Saurabh Saha plans 2.3M CNTA share sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder has filed a Rule 144 notice to sell 2,300,000 shares of Class A common stock through UBS Financial Services, with an aggregate market value of $52,601,000, targeting an approximate sale date of 01/21/2026 on NASDAQ. The form also lists 1,344,478 shares as the number of shares or other units outstanding.

The shares to be sold were acquired on 01/21/2026 via a stock option exercise from the issuer, paid in cash. Over the prior three months, the same seller, Saurabh Saha, reported multiple open-market sales of common stock, including 124,335 shares on 01/02/2026 for $2,976,499 and 1,100,000 shares on 01/15/2026 for $24,666,295, along with several other sizable transactions in early January.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CNTA shares are planned for sale under this Rule 144 notice?

The notice covers a proposed sale of 2,300,000 shares of Class A common stock, with an aggregate market value of $52,601,000, to be sold through UBS Financial Services on or around 01/21/2026 on NASDAQ.

How and when were the CNTA shares to be sold under Rule 144 acquired?

The 2,300,000 Class A common shares listed for sale were acquired on 01/21/2026 via a stock option exercise from the issuer, with the form indicating the nature of payment as cash.

What prior CNTA share sales by Saurabh Saha are disclosed in the past 3 months?

The filing lists several sales of common stock by Saurabh Saha during early January 2026, including 124,335 shares sold on 01/02/2026 for $2,976,499 and 1,100,000 shares sold on 01/15/2026 for $24,666,295, along with multiple additional trades on dates from 01/05/2026 through 01/16/2026.

What does the Form 144 say about CNTA shares outstanding?

In the securities information section, the notice lists 1,344,478 as the number of shares or other units outstanding for the Class A common stock referenced in the proposed Rule 144 sale.

Which broker and exchange are involved in the planned CNTA Rule 144 sale?

The proposed sale of 2,300,000 Class A common shares is to be executed through UBS Financial Services Inc., with the filing identifying NASDAQ as the securities exchange.

What representation does the seller make in this CNTA Rule 144 notice?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Centessa Pharmaceuticals Plc

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Latest SEC Filings

CNTA Stock Data

3.39B
133.70M
0.49%
93.69%
3.93%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
ALTRINCHAM, CHESHIRE